Aptevo Therapeutics
APVO
0 hedge funds and large institutions have $1.79M invested in Aptevo Therapeutics in 2020 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
79% less capital invested
Capital invested by funds: $8.62M → $1.79M (-$6.83M)
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$2.73M |
| 2 |
PWAM
Park West Asset Management
San Francisco,
California
|
-$654K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$354K |
| 4 |
FM
Fondren Management
Houston,
Texas
|
-$79K |
| 5 |
WG
Winton Group
London,
United Kingdom
|
-$74K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PWAM
26
Park West Asset Management
San Francisco,
California
| – | -$654K | – | – |
|
|
PAG
27
Private Advisor Group
Morristown,
New Jersey
| – | -$16K | – | – |
|
|
QI
28
QS Investors
New York
| – | -$1K | – | – |
|
|
SWA
29
SFMG Wealth Advisors
Plano,
Texas
| – | -$10K | – | – |
|
30
State Street
Boston,
Massachusetts
| – | -$8K | – | – |
|
31
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$10K | – | – |
|
|
WG
32
Winton Group
London,
United Kingdom
| – | -$74K | – | – |
|
APVO Hedge Fund Activity: Q1 2020 in Review
0 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Aptevo Therapeutics (APVO) for Q1 2020, worth a combined $1.79M — down 79% from $8.62M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of APVO and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Stonepine Capital Management, exiting entirely with an estimated $2.73M sold.
- 0 institutional investors held Aptevo Therapeutics (APVO) as of Q1 2020, down from 1 in Q4 2019.
- Funds reported $1.79M of Aptevo Therapeutics stock for Q1 2020, down 79% quarter-over-quarter.
- 0 funds opened new Aptevo Therapeutics positions in Q1 2020 and 1 closed out, a net change of -1 holder.
- The largest Aptevo Therapeutics seller in Q1 2020 was Stonepine Capital Management, an estimated $2.73M sold.
Based on aggregated 13F filings for Q1 2020.